HN2000000242A - HYGROMYCIN DERIVATIVES - Google Patents

HYGROMYCIN DERIVATIVES

Info

Publication number
HN2000000242A
HN2000000242A HN2000000242A HN2000000242A HN2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A HN 2000000242 A HN2000000242 A HN 2000000242A
Authority
HN
Honduras
Prior art keywords
hygromycin
derivatives
hygromycin derivatives
present
invention refers
Prior art date
Application number
HN2000000242A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to HN2000000242A priority Critical patent/HN2000000242A/en
Publication of HN2000000242A publication Critical patent/HN2000000242A/en

Links

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE HIGROMICINATHE PRESENT INVENTION REFERS TO HYGROMYCIN DERIVATIVES

HN2000000242A 2000-10-26 2000-10-26 HYGROMYCIN DERIVATIVES HN2000000242A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2000000242A HN2000000242A (en) 2000-10-26 2000-10-26 HYGROMYCIN DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2000000242A HN2000000242A (en) 2000-10-26 2000-10-26 HYGROMYCIN DERIVATIVES

Publications (1)

Publication Number Publication Date
HN2000000242A true HN2000000242A (en) 2001-04-11

Family

ID=53190389

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2000000242A HN2000000242A (en) 2000-10-26 2000-10-26 HYGROMYCIN DERIVATIVES

Country Status (1)

Country Link
HN (1) HN2000000242A (en)

Similar Documents

Publication Publication Date Title
HN2001000139A (en) STABILIZED INTERLEUQUINA 2
HN1999000089A (en) ZIPRASIDONE FORMULATIONS
HN1999000125A (en) NEW SUBSTITUTED DERIVATIVES OF PIRAZOLE
HN1999000155A (en) 4-CARBOXYAMINO-2-METHYL-1,2,3,4-TETRAHYDROKINOLINS
HN1998000057A (en) NICOTINAMIDE DERIVATIVES
HN1999000066A (en) PHARMACEUTICAL FORMULATIONS
HN1997000090A (en) PIRIDILPIRROL COMPOUNDS
HN1998000030A (en) 2-AMINO-6- (4FENOXI-2-SUBSTITUTED) -PIRIDINES SUBSTITUTED
HN1998003689A (en) AZETIDINS
HN1998000158A (en) ISOQUINOLINS
HN1998000106A (en) PARENTERAL COMPOSITIONS OF ALATROFLAXACINO
HN1998000199A (en) THERAPEUTIC AGENTS
PA8543701A1 (en) PHENYL-HETEROCICLIL-ETERES
HN1998000102A (en) SOLTRILIZED COMPOSITIONS OF SERTRALINA
HN1999000202A (en) HYGROMYCIN DERIVATIVES
HN2000000242A (en) HYGROMYCIN DERIVATIVES
HN2000000276A (en) THIAZOLILAMIDE DERIVATIVES
HN2001000135A (en) PURINA DERIVATIVES
HN2000000188U (en) COMBINED PLOW
HN2000000205A (en) PURINA DERIVATIVES
HN1998000072A (en) TETRAZOLES
HN2000000062A (en) SUBSTITUTED BENZOLACTAMA COMPOUNDS
HN2000000247A (en) COMBINATION CHEMOTHERAPY
HN2000000015A (en) DANNILMA ELECTRONIC SYSTEM
HN1999000171A (en) ORAL CONCENTRATE OF SERTRALINA.